On March 16, 2026, Tonix Pharmaceuticals Holding Corp. announced the dismissal of EisnerAmper LLP as its independent registered public accounting firm. The decision was made by the Audit Committee of the Company's Board of Directors and was not related to any disagreements regarding accounting principles or practices. EisnerAmper's audit reports for the fiscal years ending December 31, 2025, and December 31, 2024, did not contain any adverse opinions or disclaimers, although they did raise concerns about the company's ability to continue as a going concern due to ongoing losses and negative cash flows. Following the dismissal, Tonix appointed PricewaterhouseCoopers LLP (PwC) as its new auditor for the fiscal year ending December 31, 2026. The selection of PwC was also approved by the Audit Committee. The company reported no disagreements with EisnerAmper during the last two fiscal years, and no reportable events were noted, aside from previously disclosed material weaknesses in internal controls over financial reporting. These weaknesses have since been remediated, and the company did not restate its financial statements. The transition to PwC is expected to provide a fresh perspective on the company's financial reporting as it continues to navigate its operational challenges.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.